ABVC BioPharma, Inc.
ABVC
$2.77
$0.04011.47%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 453.50K | 217.30K | 313.10K | 208.20K | 200.00K |
| Total Receivables | 1.42M | 537.10K | 1.16M | 1.22M | 1.27M |
| Inventory | 11.50K | 11.50K | -- | -- | -- |
| Prepaid Expenses | 195.00K | 96.40K | 96.20K | 91.30K | 100.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 688.10K | 607.40K | 615.40K | 632.50K | 618.50K |
| Total Current Assets | 2.77M | 1.47M | 2.18M | 2.15M | 2.19M |
|
|
|||||
| Total Current Assets | 2.77M | 1.47M | 2.18M | 2.15M | 2.19M |
| Net Property, Plant & Equipment | 8.67M | 8.70M | 1.15M | 8.44M | 8.54M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.96M | 1.94M | 1.95M | 1.54M | 1.53M |
| Total Assets | 16.24M | 14.88M | 7.54M | 14.46M | 14.63M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 3.08M | 3.00M | 3.21M | 3.18M | 3.31M |
| Short-term Debt | 1.30M | 1.37M | 1.46M | 1.11M | 1.03M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 695.30K | 1.34M | 1.50M | 1.49M | 1.48M |
| Total Finance Division Other Current Liabilities | 1.45M | 1.02M | 391.90K | 532.10K | 739.20K |
| Total Other Current Liabilities | 1.45M | 1.02M | 391.90K | 532.10K | 739.20K |
| Total Current Liabilities | 6.53M | 6.73M | 6.56M | 6.32M | 6.55M |
|
|
|||||
| Total Current Liabilities | 6.53M | 6.73M | 6.56M | 6.32M | 6.55M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.30M | 1.37M | 1.46M | 1.11M | 1.03M |
| Capital Leases | 177.10K | 167.00K | 236.80K | 142.20K | 228.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 41.70K | 21.70K | 21.70K | 25.70K | 27.70K |
| Total Liabilities | 6.75M | 6.92M | 6.82M | 6.48M | 6.81M |
|
|
|||||
| Common Stock & APIC | 86.40M | 83.63M | 78.61M | 87.32M | 87.09M |
| Retained Earnings | -72.05M | -69.79M | -68.95M | -70.55M | -70.37M |
| Treasury Stock & Other | -7.34M | -8.43M | -8.43M | -8.41M | -8.44M |
| Total Common Equity | 7.01M | 5.40M | 1.23M | 8.36M | 8.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.01M | 5.40M | 1.23M | 8.36M | 8.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 2.48M | 2.55M | -502.20K | -379.10K | -465.20K |
| Total Equity | 9.49M | 7.96M | 724.00K | 7.98M | 7.83M |
|
|
|||||